Healthcare provider profile · identity verified

Gerald Lee, MD

Internal Medicine · GRAND RAPIDS, MI · NPI 1265437420

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	673	189
Levothyroxine Sodium	Levothyroxine Sodium	425	106
Lisinopril	Lisinopril	369	106
Amlodipine Besylate	Amlodipine Besylate	338	104
Metoprolol Succinate	Metoprolol Succinate	310	82
Losartan Potassium	Losartan Potassium	241	71
Omeprazole	Omeprazole	238	80
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	222	40
Simvastatin	Simvastatin	206	56
Metformin Hcl	Metformin Hcl	200	58
Tamsulosin Hcl	Tamsulosin Hcl	163	53
Hydrochlorothiazide	Hydrochlorothiazide	151	44
Gabapentin	Gabapentin	143	49
Pioglitazone Hcl	Pioglitazone Hcl	139	38
Trazodone Hcl	Trazodone Hcl	126	41
Furosemide	Furosemide	124	41
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	121	38
Pravastatin Sodium	Pravastatin Sodium	119	33
Pantoprazole Sodium	Pantoprazole Sodium	118	36
Fluticasone Propionate	Fluticasone Propionate	111	41
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	111	31
Rosuvastatin Calcium	Rosuvastatin Calcium	102	28
Eliquis	Apixaban	101	23
Duloxetine Hcl	Duloxetine Hcl	100	25
Metformin Hcl Er	Metformin Hcl	99	30
Sertraline Hcl	Sertraline Hcl	99	34
Meloxicam	Meloxicam	97	31
Alendronate Sodium	Alendronate Sodium	88	29
Albuterol Sulfate Hfa	Albuterol Sulfate	81	37
Jardiance	Empagliflozin	80	25
Carvedilol	Carvedilol	79	19
Prednisone	Prednisone	78	59
Finasteride	Finasteride	74	23
Escitalopram Oxalate	Escitalopram Oxalate	70	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	69	25
Alprazolam	Alprazolam	66	21
Doxazosin Mesylate	Doxazosin Mesylate	66	17
Potassium Chloride	Potassium Chloride	62	18
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	61	22
Metoprolol Tartrate	Metoprolol Tartrate	60	19
Aripiprazole	Aripiprazole	59	19
Fluoxetine Hcl	Fluoxetine Hcl	52	13
Ibuprofen	Ibuprofen	52	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	52	14
Zolpidem Tartrate	Zolpidem Tartrate	52	13
Atenolol	Atenolol	51	14
Tramadol Hcl	Tramadol Hcl	50	17
Allopurinol	Allopurinol	49	16
Buspirone Hcl	Buspirone Hcl	48	15
Hydroxyzine Pamoate	Hydroxyzine Pamoate	47	15
Citalopram Hbr	Citalopram Hydrobromide	43	14
Glipizide Er	Glipizide	42	12
Mounjaro	Tirzepatide	42	suppressed
Baclofen	Baclofen	41	22
Trulicity	Dulaglutide	41	11
Montelukast Sodium	Montelukast Sodium	39	12
Venlafaxine Hcl Er	Venlafaxine Hcl	39	suppressed
Bupropion Xl	Bupropion Hcl	38	11
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	38	11
Doxycycline Hyclate	Doxycycline Hyclate	37	35
Glipizide	Glipizide	37	13
Sumatriptan Succinate	Sumatriptan Succinate	37	suppressed
Ezetimibe	Ezetimibe	36	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	35	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	35	22
Betamethasone Dipropionate	Betamethasone Dipropionate	34	18
Bupropion Hcl Sr	Bupropion Hcl	34	13
Celecoxib	Celecoxib	34	suppressed
Famotidine	Famotidine	34	suppressed
Ipratropium Bromide	Ipratropium Bromide	32	14
Diclofenac Sodium	Diclofenac Sodium	31	15
Hydralazine Hcl	Hydralazine Hcl	31	12
Lovastatin	Lovastatin	31	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	31	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	29	suppressed
Amoxicillin	Amoxicillin	28	17
Ketoconazole	Ketoconazole	28	suppressed
Pregabalin	Pregabalin	28	13
Ozempic	Semaglutide	27	suppressed
Paroxetine Hcl	Paroxetine Hcl	27	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	26	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	26	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	25	suppressed
Cephalexin	Cephalexin	24	23
Hydrocortisone	Hydrocortisone	24	13
Dulera	Mometasone/Formoterol	22	suppressed
Lansoprazole	Lansoprazole	22	suppressed
Myrbetriq	Mirabegron	22	suppressed
Chlorthalidone	Chlorthalidone	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Acyclovir	Acyclovir	20	suppressed
Humalog Kwikpen U-100	Insulin Lispro	20	suppressed
Lidocaine	Lidocaine	20	suppressed
Minocycline Hcl	Minocycline Hcl	20	suppressed
Nystatin	Nystatin	20	17
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	19	suppressed
Estradiol	Estradiol	19	suppressed
Raloxifene Hcl	Raloxifene Hcl	19	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	18	suppressed
Glimepiride	Glimepiride	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Eszopiclone	Eszopiclone	17	suppressed
Mupirocin	Mupirocin	17	11
Fluconazole	Fluconazole	16	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	16	suppressed
Lorazepam	Lorazepam	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Spiriva Handihaler	Tiotropium Bromide	16	suppressed
Spiriva Respimat	Tiotropium Bromide	16	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	15	suppressed
Benzonatate	Benzonatate	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Spironolactone	Spironolactone	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Clopidogrel	Clopidogrel Bisulfate	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Terbinafine Hcl	Terbinafine Hcl	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Azithromycin	Azithromycin	13	13
Benazepril Hcl	Benazepril Hcl	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	11
Diazepam	Diazepam	13	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Methadone Hcl	Methadone Hcl	12	suppressed
Nabumetone	Nabumetone	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Torsemide	Torsemide	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	11
Valsartan	Valsartan	12	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	11	suppressed
Calcitriol	Calcitriol	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Risperidone	Risperidone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error